Lynnet Bulambo
Psychiatry · Roswell, NMNPI 1063891307
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Neuronetics, Inc. accounts for 71.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,445 and has fallen 95.1% since, to $71 in 2025. Among psychiatry clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $56.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$1K
- AbbVie$288
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
- Alkermes, Inc.$67
- Teva Pharmaceuticals USA, Inc.$47
- Lundbeck LLC$33
- plus $37 from 2 others
What the payments were for
- Travel & lodging$86845%
- Food & beverage$1,01953%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 2 | $1,380 |
| AbbVie(2 entities) | 18 | $288 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $81 |
| Alkermes, Inc. | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,380
- VRAYLAR$122
How this compares
$1,934 in reported general payments places this provider in the 90th percentile of 174 psychiatry providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 36 | $91,794 |
| LybalviOlanzapine/Samidorphan Malate | 21 | $46,419 |
| VraylarCariprazine Hcl | 17 | $27,019 |
| CaplytaLumateperone Tosylate | 14 | $25,588 |
| Aripiprazole | 79 | $5,845 |
| Quetiapine Fumarate | 146 | $2,749 |
| Bupropion XlBupropion Hcl | 64 | $2,414 |
| Gabapentin | 222 | $2,395 |
| Olanzapine | 103 | $2,303 |
| Hydroxyzine Hcl | 121 | $2,126 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 60 | $2,087 |
| Ziprasidone Hcl | 69 | $2,053 |
| Trazodone Hcl | 163 | $1,878 |
| Alprazolam | 113 | $1,333 |
| Benztropine Mesylate | 69 | $1,166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $24 | $91,79436 claims |
| Alkermes, Inc.Lybalvi | $67 | $46,41921 claims |
| AbbVieVraylar | $288 | $27,01917 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $81 | $25,58814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 174 psychiatry providers in New Mexico.
Other psychiatry in Roswell
- Richard SmithRoswell$3K
- Patricio EscalonaAlbuquerque$487K
- Mauricio TohenAlbuquerque$160K
- Shiva SharmaAlbuquerque$140K
- Jefferson DavisSanta Fe$53K
- Ernest FloresLas Cruces$25K
- Yvonne HallRio Rancho$11K
- Javier VeraAlbuquerque$8K
- Nancy MartinAlbuquerque$6K
- Reuben SutterAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.